{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:55:26Z","timestamp":1781758526995,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This case report aims to enhance awareness and understanding of intracranial mesenchymal tumors with FET::CREB fusion by illustrating the associated diagnostic challenges, thereby contributing to the limited literature on this rare entity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This report presents a case of a 58-year-old female who presented with a persistent headache. Neuroimaging revealed a well-defined cystic mass in the right temporoparietal lobe. The patient underwent gross total resection (GTR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Histopathological analysis was consistent with an intracranial mesenchymal tumor, showing immunopositivity for Desmin, MUC4, CD99, and ALK. Next-generation sequencing identified an EWSR1::ATF1 gene fusion, confirming the diagnosis of an intracranial mesenchymal tumor, FET::CREB fusion-positive. Approximately two years postoperatively, follow-up imaging revealed local tumor recurrence, which was managed with a second GTR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the diagnostic challenges, potential for recurrence, and importance of molecular profiling in the accurate diagnosis of this rare tumor entity. GTR remains the primary treatment, though the long-term biological behavior and optimal management strategies require further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1808296","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:40:01Z","timestamp":1781757601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intracranial mesenchymal tumor with FET::CREB fusion: a rare case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Weina","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Ward 505, The First People\u2019s Hospital of Jiashan County","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Jiaxing University","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000788","article-title":"EWSR1 fusions with CREB family transcription factors define a novel myxoid mesenchymal tumor with predilection for intracranial location","volume":"41","author":"Kao","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0646-5","article-title":"EWSR1\/FUS\u2013CREB fusions define a distinctive Malignant epithelioid neoplasm with predilection for mesothelial-lined cavities","volume":"33","author":"Argani","year":"2020","journal-title":"Mod Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20491","article-title":"EWSR1\u2010CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma","volume":"46","author":"Antonescu","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000364","article-title":"Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component","volume":"39","author":"Ska\u0301lova\u0301","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000864","article-title":"A subset of Malignant mesotheliomas in young adults are associated with recurrent EWSR1\/FUS-ATF1 fusions","volume":"41","author":"Desmeules","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20881","article-title":"EWSR1\u2010ATF1 fusion is a novel and consistent finding in hyalinizing clear\u2010cell carcinoma of salivary gland","volume":"50","author":"Antonescu","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181453451","article-title":"Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes","volume":"32","author":"Dunham","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12504","article-title":"Intracranial myxoid mesenchymal tumors with EWSR1\u2013CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity","volume":"28","author":"Bale","year":"2017","journal-title":"Brain Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12918","article-title":"Intracranial mesenchymal tumor with FET-CREB fusion-a unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms","volume":"31","author":"Sloan","year":"2021","journal-title":"Brain Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13010","article-title":"An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB- fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts","volume":"32","author":"Tauzi\u00e8de-Espariat","year":"2021","journal-title":"Brain Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noag001","article-title":"Intracranial mesenchymal tumor, FET-CREB fusion-positive: an integrative analysis of 81 cases","volume":"28","author":"Wu","year":"2026","journal-title":"Neuro Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12814","article-title":"Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type","volume":"42","author":"Kim","year":"2022","journal-title":"Neuropathology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa357","article-title":"Intracranial myxoid mesenchymal tumor\/myxoid subtype angiomatous fibrous histiocytoma: diagnostic and prognostic challenges","volume":"88","author":"Domingo","year":"2020","journal-title":"Neurosurgery"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3171\/2009.8.Jns081518","article-title":"Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage","volume":"112","author":"Ochalski","year":"2010","journal-title":"J Neurosurg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.355080","article-title":"Intracranial myxoid mesenchymal tumour with EWSR1-ATF1 fusion sans myxoid stroma \u2013 report of a newer entity with brief review of literature","volume":"70","author":"Shaikh","year":"2022","journal-title":"Neurol India"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae064.679","article-title":"OTHR-08. Clinical management of two pediatric cases of intracranial mesenchymal tumors with FET::CREB fusions","volume":"26","author":"Lucas","year":"2024","journal-title":"Neuro Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab016","article-title":"Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy","volume":"3","author":"De Los Santos","year":"2021","journal-title":"Neuro-Oncol Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000005346","article-title":"Intracranial mesenchymal tumor, FET-CREB fusion positive, evaluated with 18F-FET and 18F-FDG PET\/CT","volume":"49","author":"Engkeb\u00f8lle","year":"2024","journal-title":"Clin Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000001425","article-title":"The role of amino acid PET in the era of checkpoint inhibitors and targeted therapy for brain tumor treatment","volume":"38","author":"Galldiks","year":"2025","journal-title":"Curr Opin Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/RLU.0000000000006459","article-title":"Extracranial metastases from FET-CREB fusion-positive intracranial mesenchymal tumor on FDG PET\/CT","volume":"49","author":"Wang","year":"2026","journal-title":"Clin Nucl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1808296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:40:08Z","timestamp":1781757608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1808296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1808296"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1808296","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"article-number":"1808296"}}